ZA983917B - Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity - Google Patents
Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activityInfo
- Publication number
- ZA983917B ZA983917B ZA983917A ZA983917A ZA983917B ZA 983917 B ZA983917 B ZA 983917B ZA 983917 A ZA983917 A ZA 983917A ZA 983917 A ZA983917 A ZA 983917A ZA 983917 B ZA983917 B ZA 983917B
- Authority
- ZA
- South Africa
- Prior art keywords
- antiviral
- pharmaceutical
- glycyrrhizic acid
- composition
- antiviral activity
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 title 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 title 1
- 229960004949 glycyrrhizic acid Drugs 0.000 title 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 title 1
- 239000001685 glycyrrhizic acid Substances 0.000 title 1
- 235000019410 glycyrrhizin Nutrition 0.000 title 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI001119A IT1291366B1 (it) | 1997-05-14 | 1997-05-14 | Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA983917B true ZA983917B (en) | 1998-11-09 |
Family
ID=11377123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA983917A ZA983917B (en) | 1997-05-14 | 1998-05-08 | Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6329339B1 (enExample) |
| EP (1) | EP0980254B1 (enExample) |
| JP (2) | JP2001525814A (enExample) |
| KR (1) | KR100592193B1 (enExample) |
| CN (1) | CN1114447C (enExample) |
| AR (1) | AR012849A1 (enExample) |
| AT (1) | ATE212232T1 (enExample) |
| AU (1) | AU740944B2 (enExample) |
| BG (1) | BG64748B1 (enExample) |
| CA (1) | CA2289550A1 (enExample) |
| CZ (1) | CZ291932B6 (enExample) |
| DE (1) | DE69803565T2 (enExample) |
| DK (1) | DK0980254T3 (enExample) |
| EA (1) | EA003126B1 (enExample) |
| ES (1) | ES2170501T3 (enExample) |
| GE (1) | GEP20022672B (enExample) |
| HU (1) | HU224956B1 (enExample) |
| IL (2) | IL132651A0 (enExample) |
| IT (1) | IT1291366B1 (enExample) |
| PL (1) | PL189218B1 (enExample) |
| PT (1) | PT980254E (enExample) |
| SK (1) | SK283584B6 (enExample) |
| TR (1) | TR199902730T2 (enExample) |
| UA (1) | UA63955C2 (enExample) |
| WO (1) | WO1998051334A1 (enExample) |
| ZA (1) | ZA983917B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7151082B2 (en) * | 1999-02-11 | 2006-12-19 | The Feinstein Institute For Medical Research | Antagonists of HMG1 for treating inflammatory conditions |
| US6303321B1 (en) * | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
| US7304034B2 (en) * | 2001-05-15 | 2007-12-04 | The Feinstein Institute For Medical Research | Use of HMGB fragments as anti-inflammatory agents |
| WO2003088914A2 (en) * | 2002-04-18 | 2003-10-30 | The University Of Iowa Research Foundation | Methods of inhibiting and treating bacterial biofilms by metal chelators |
| US7696169B2 (en) * | 2003-06-06 | 2010-04-13 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| EP1668035A2 (en) * | 2003-09-11 | 2006-06-14 | Critical Therapeutics, Inc. | Monoclonal antibodies against hmgb1 |
| EP1909834A2 (en) * | 2005-07-18 | 2008-04-16 | Critical Therapeutics, Inc. | Use of hmgb1 antagonists for the treatment of inflammatory skin conditions |
| CA2631212A1 (en) * | 2005-11-28 | 2007-07-05 | Medimmune, Llc | Antagonists of hmgb1 and/or rage and methods of use thereof |
| IT1391170B1 (it) * | 2008-08-07 | 2011-11-18 | D M G Italia S R L | Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale |
| CA2809031C (en) * | 2010-08-25 | 2018-10-16 | Weijian Zhang | Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis |
| US9416151B2 (en) | 2010-08-25 | 2016-08-16 | Lurong ZHANG | Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis |
| CN106029089B (zh) * | 2014-02-21 | 2020-12-29 | 丘比株式会社 | 诺如病毒灭活剂及其制造方法 |
| US12447166B2 (en) | 2016-02-25 | 2025-10-21 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
| US12594285B2 (en) | 2016-02-25 | 2026-04-07 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
| CA3014764A1 (en) * | 2016-02-25 | 2017-08-31 | Applied Biological Laboratories, Inc. | Compositions and methods for protecting against airborne pathogens and irritants |
| CN109022351B (zh) * | 2018-09-28 | 2021-10-19 | 广州奇龙生物科技有限公司 | 重组人溶菌酶的新应用 |
| EP4144363A4 (en) * | 2020-04-27 | 2024-05-29 | Guangzhou Century Clinical Research Co., Ltd | Drug, food and application of anti-coronavirus infection |
| US20220305092A1 (en) * | 2020-04-27 | 2022-09-29 | Guangzhou Century Clinical Research Co., Ltd | Medicament and food for preventing or treating novel coronavirus pneumonia covid-19 and use thereof |
| MX2021005280A (es) | 2021-05-04 | 2022-02-23 | Spv Timser S A P I De C V | Composicion farmaceutica que contiene triterpenoides pentaciclicos. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH085800B2 (ja) * | 1986-12-19 | 1996-01-24 | エーザイ株式会社 | 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤 |
| JP2838720B2 (ja) * | 1989-10-31 | 1998-12-16 | ゼリア新薬工業株式会社 | 安定な点眼剤 |
| JP4056099B2 (ja) * | 1996-05-09 | 2008-03-05 | 森永乳業株式会社 | 水生動物の寄生生物性疾患の予防および治療剤 |
-
1997
- 1997-05-14 IT IT97MI001119A patent/IT1291366B1/it active IP Right Grant
-
1998
- 1998-05-06 SK SK1544-99A patent/SK283584B6/sk not_active IP Right Cessation
- 1998-05-06 GE GEAP19985126A patent/GEP20022672B/en unknown
- 1998-05-06 JP JP54879998A patent/JP2001525814A/ja not_active Ceased
- 1998-05-06 HU HU0002985A patent/HU224956B1/hu not_active IP Right Cessation
- 1998-05-06 KR KR1019997010372A patent/KR100592193B1/ko not_active Expired - Fee Related
- 1998-05-06 AU AU77646/98A patent/AU740944B2/en not_active Ceased
- 1998-05-06 TR TR1999/02730T patent/TR199902730T2/xx unknown
- 1998-05-06 ES ES98925588T patent/ES2170501T3/es not_active Expired - Lifetime
- 1998-05-06 EA EA199901024A patent/EA003126B1/ru not_active IP Right Cessation
- 1998-05-06 CA CA002289550A patent/CA2289550A1/en not_active Abandoned
- 1998-05-06 CZ CZ19993991A patent/CZ291932B6/cs not_active IP Right Cessation
- 1998-05-06 PT PT98925588T patent/PT980254E/pt unknown
- 1998-05-06 US US09/423,611 patent/US6329339B1/en not_active Expired - Fee Related
- 1998-05-06 PL PL98336802A patent/PL189218B1/pl not_active IP Right Cessation
- 1998-05-06 DE DE69803565T patent/DE69803565T2/de not_active Expired - Fee Related
- 1998-05-06 WO PCT/EP1998/002797 patent/WO1998051334A1/en not_active Ceased
- 1998-05-06 AT AT98925588T patent/ATE212232T1/de not_active IP Right Cessation
- 1998-05-06 IL IL13265198A patent/IL132651A0/xx active IP Right Grant
- 1998-05-06 EP EP98925588A patent/EP0980254B1/en not_active Expired - Lifetime
- 1998-05-06 DK DK98925588T patent/DK0980254T3/da active
- 1998-05-06 CN CN98805037A patent/CN1114447C/zh not_active Expired - Fee Related
- 1998-05-08 ZA ZA983917A patent/ZA983917B/xx unknown
- 1998-05-13 AR ARP980102218A patent/AR012849A1/es active IP Right Grant
- 1998-06-05 UA UA99126790A patent/UA63955C2/uk unknown
-
1999
- 1999-10-29 IL IL132651A patent/IL132651A/en not_active IP Right Cessation
- 1999-12-08 BG BG103968A patent/BG64748B1/bg unknown
-
2008
- 2008-12-25 JP JP2008331229A patent/JP2009102370A/ja not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0002985A3 (en) | Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity | |
| DE69828512D1 (de) | Granulierter plasmaproteinfutterzusatz mit erhöhter biowirksamkeit | |
| EP0950665A4 (en) | PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM | |
| EP1024130A4 (en) | BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE | |
| HUP0100178A3 (en) | Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof | |
| ZA985352B (en) | Barbituric acid derivatives with antimetastatic and antitumor activity. | |
| IL128144A0 (en) | Benzamidine derivatives and their use as medicaments with an ltb4-antagonistic activity | |
| HUP0105105A3 (en) | Macrolides with anti-inflammatory activity and medicaments containing them | |
| IL126247A0 (en) | Novel imidazolidine derivatives their preparation their use and pharmaceutical preparations comprising them | |
| AU8016398A (en) | Peptides with antiviral activity | |
| HU9701080D0 (en) | Pharmaceutical composition of antiviral activity | |
| ZA9811655B (en) | Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same | |
| HUP0003189A3 (en) | Pharmaceutical composition comprising fexofenadine and its derivatives | |
| ZA986756B (en) | Modified polypeptides with high activity and reduced allergenicity | |
| AU8168898A (en) | Interferon stimulating protein and uses thereof | |
| AU1821300A (en) | Peptides having anti-cancer and anti-inflammatory activity | |
| ZA987633B (en) | Dried biologically or therapeutically active preparations | |
| IL149506A0 (en) | Human heparanase-related polypeptide and nucleic acid | |
| SI0980254T1 (en) | Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity | |
| IL136988A0 (en) | Novel nucleic acid and polypeptide | |
| NZ325260A (en) | Covalent-lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments | |
| HUP9901165A3 (en) | Thiamorphinans with neuroprotective activity, pharmaceutical compositions and use of the same | |
| KR0185794B1 (en) | Pharmaceutical preparations having anti-fibrotic activity | |
| ZA977043B (en) | Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells | |
| GB9725149D0 (en) | Insecticidal gene and peptide |